Compound or practice · Supplement

Serrapeptase

A proteolytic enzyme sold for inflammation and pain with weak, low-quality human evidence.

Overall grade
Grade D
Last revised
1
graded outcome
0
references listed

A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.

1 at grade D — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Post-surgical swelling / painEvidence grade D

    Low-quality

    Triviallow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Post-surgical swelling / pain (grade D).

The evidence in words

What it is

Serrapeptase is a proteolytic enzyme (originally from silkworm gut bacteria) marketed for inflammation, pain, and mucus.

How it works

It breaks down proteins and is proposed to reduce inflammation, edema, and mucus viscosity.

What the evidence shows

Older, mostly low-quality studies suggest reduced post-surgical swelling and ENT mucus; rigorous modern evidence is scarce and some regulators removed approvals. Plausible but poorly substantiated.

How to use it

Enteric-coated on an empty stomach if trialing.

Safety & interactions

Generally tolerated; theoretical bleeding and drug-absorption effects.

Bottom line

Popular for inflammation but thinly evidenced. Not a priority; bromelain has somewhat better support.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

If trialing
Enteric-coated, empty stomach.

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own.

Last revised . A grade is this entry's reading of the evidence, not medical advice.